1. Home
  2. HLIT vs TRVI Comparison

HLIT vs TRVI Comparison

Compare HLIT & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmonic Inc.

HLIT

Harmonic Inc.

HOLD

Current Price

$12.51

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$14.19

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLIT
TRVI
Founded
1988
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
HLIT
TRVI
Price
$12.51
$14.19
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$14.67
$21.55
AVG Volume (30 Days)
1.6M
1.8M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.91
EPS
0.07
N/A
Revenue
N/A
N/A
Revenue This Year
$42.73
N/A
Revenue Next Year
$18.36
N/A
P/E Ratio
$190.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.80
$5.38
52 Week High
$15.39
$16.12

Technical Indicators

Market Signals
Indicator
HLIT
TRVI
Relative Strength Index (RSI) 64.33 51.15
Support Level $9.92 $10.07
Resistance Level N/A $16.12
Average True Range (ATR) 0.76 0.80
MACD 0.11 -0.05
Stochastic Oscillator 45.30 40.11

Price Performance

Historical Comparison
HLIT
TRVI

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: